Eosinophilic gastroenteritis is a rare disease characterized by prominent eosinophilic tissue infiltration of the gastrointestinal tract. Here, we report a case of eosinophilic gastroenteritis in an 18-yearold patient with prolonged nephrotic syndrome who presented with abdominal pain and peripheral hypereosinophilia. During the previous 2 years, he had visited local Emergency Department several times because of epigastric pain and nausea. He had been treated with steroid-dependent nephrotic syndrome since 3 years of age. Tests ruled out allergic and parasitic disease etiologies. Gastroduodenoscopy with biopsy revealed marked eosinophilic infiltration in the duodenum. Renal biopsy findings indicated minimal change disease spectrum without eosinophilic infiltration. The oral deflazacort dosage was increased, and the patient was discharged after abdominal pain resolved. To our knowledge, this is the first report of eosinophilic gastroenteritis in a patient with minimal change disease.
Introduction
Nephrotic syndrome (NS) in children is typically idiopathic, but may also occur sec ondary to other diseases including eosinophilic disorders 14) . Eosinophilic gastroenteritis (EG) is an eosinophilic disease characterized by eosinophilic inflammation of the gastro intestinal (GI) tract 5, 6) . There have been few previous reports of these 2 distinct diseases coexisting in the same patient 7) . Here we describe a rare case of EG presenting as abdominal pain with peripheral eosinophilia in prolonged NS.
Case report
An 18yearold male was admitted with epigastric pain and nausea. During the previous 2 years he visited a local Emergency Department several times with a similar clinical presentation. He had been treated for steroiddependent NS since he was three years of age, and was taking 6 mg (0.1 mg/kg) of oral deflazacort every other day when admitted. There was no history of allergic disease such as food allergies, asthma or atopic dermatitis.
On admission, the results of laboratory tests included leukocyte count, 18,0×10
Korean J Pediatr 2016;59(Suppl 1):S72-75 tomogarphic scans were performed due to elevated amylase, and revealed wall thickening from the distal esophagus to the proxi mal jejunum and distal jejunal loops without evidence of pan creatitis (Fig. 1 The patient had grossly edematous findings without erosion or ulcer in duodenum on esophagogastroduodenoscopy. Bio psy specimens of the duodenal mucosa showed eosinophilic infiltra tion in the lamina propria up to 35/highpower field ( Fig. 2 ).
Renal biopsy was performed to evaluate the relationship between hypereosinophilic syndrome (HES) and renal disease. The biopsy findings were (1) within the minimal change disease (MCD) spectrum with IgM deposits (IgM nephropathy), and (2) mild tubular atrophy with interstitial fibrosis. There was no infiltration of inflammatory cells, even eosinophils. Chest radiography and cardiac sonography were unremarkable. A diagnosis of EG and relapsed NS was made. On the 6th hospital day, the patient com plained of epigastric pain again and the quantity of oral deflaza cort was increased to 54 mg (1.2 mg/kg) per day, after which his symptoms improved. On the 11th hospital day, the patient was discharged with decreased pro teinuria (spot urine protein/crea tinine, 2.0) and decreased eo sinophilia (absolute eosinophil count, 72/µL). On followup, mild to moderate peri pheral eosinophilia was a continuing issue, but the patient did not complained of further abdominal pain for 2 years. But recently he was admitted again for repetitive severe epigastric pain. There was severe peripheral eosinophilia (absolute eosinophil count, 5,054/µL), without proteinuria. The results of both abdomen computed tomography and duodenal biopsies were similar with previous results. Biopsy specimens of the duodenal mucosa showed eosinophilic infiltration up to 30/highpower field. His symptom was improved after treating with 50 mg of intravenous methyl prednisolone IV for 3 days and he was discharged with decreased eosinophilia, on the 8th hospital day (absolute eosinophil count, 318/µL).
Discussion
The patient reported here had peripheral eosinophilia with abdominal pain as a form of EG and MCD presenting as NS. Se rum eosinophilia and abdominal pain improved after admini stration of increased oral deflazacort. Heavy proteinuria also decreased in response to the same treatment. On second admis A B 
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sion, the patient only developed EG and was treated with methyl prednisolone. Although the etiology of EG is unknown, a history of aller gies is reported in onethird to onehalf of all patients with EG, sug gesting an allergic basis 6) . One interesting case report describes the occurrence of NS in a patient with EG and a food allergy. In this patient, a direct causal association between atopic EG and NS was suggested by renal biopsy showing immune complex glo merulonephritis with bovine serum albumin 7) . Our patient had no history of allergy and normal serum IgE. To our knowledge, this is the first case report of child or adolescent with nonatopic EG and NS.
EG may also occur secondary to systemic diseases such as con nective tissue disease or HES 5) . HES is characterized by mark ed (>1,500×10 6 /L) and persistent (>6 months) eosinophilia and multiorgan involvement without a clear etiology. The most fre quently involved organs are the cardiovascular, pulmonary, hematopoietic and nervous systems 4) . HES also involves the GI tract in 25% of cases. It may be difficult to differentiate between HES with intestinal involvement and EG 5) . EG is defined based on the following 3 criteria: the presence of GI symptoms, biopsy indicating eosinophilic infiltration of one or more areas of the GI tract from the esophagus to the colon, or characteristic radiological findings with peripheral eosinophilia, and no evidence of parasitic or extraintestinal disease 8) . Mucosal eosinophilic gastroenteritis, the most common type, manifests as abdominal pain, diarrhea, proteinlosing enteropathy and/orvo miting 5, 6, 8) , while the peripheral eosinophilic count appears nor mal in 23% to 40% of EG patients 6) . In our case, diagnosis was based on patient history (recurrent abdominal pain with nausea), infiltra tion of eosinophils on duodenal biopsy and peripheral eosino philia. The patient had GI symptoms, but no extra intestinal signs such as skin nodules, lymphadenopathy or hepatospleno megaly on physical examination, and no evidence of other organ involve ment. Primary EG is a more appropriate diagnosis for our patient than GI involvement with HES. However, patients with EG may, in rare cases, progress to HES, so longterm followup and careful exam for new signs of HES are necessary 5) . Renal involvement is rarely observed in HES 4, 9, 10) . The mecha nisms implicated in renal involvement are eosinophil cytotoxicity, mass effect due to eosinophilic infiltration and thromboembolic events secondary to cardiac damage 10) . In our case, NS anteceded the emergence of eosinophilia by several years. Thus, renal dis ease may be less likely to develop secondary to HES in our pa tient.
The first line of treatment for NS is corticosteroids 1) . Cortico steroids improve proteinuria by regulating abnormal immune reactions 11) . Corticosteroids are also the most effective antiin flammatory drugs used in the treatment of EG 5, 6, 8) . Their bene ficial effects result from (1) the suppression of the synthesis and effects of eosinophil survival factors, (2) the direct induction of eosino phil apoptosis and (3) the stimulation of engulfment by professio nal phagocytic cells 12) . Despite their different patholo gical mecha nisms, the treatment of both EG and NS is the same, and thus there is a possibility that diagnosis of EG was delayed in our case.
In summary, we report the first case of nonatopic EG with NS. However, the association of these concomitant presentations is not clear. As many as 45% of children with NS will have a fre quently relapsing course, and some will be steroiddependent 13) . This case emphasizes that, in children, treatment with prolonged steroid therapy has the potential to mask other diseases, even those that may be fatal. Thus, pediatricians should be cautious when examining child or adolescent treated with steroids for long periods.
